776 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
BMY Bristol-Myers Squibb Company $61.3 $100.03B Uptrend
Article Searches
Infinity Inks Deal With Roche for Phase II Study of IPI-549 http://www.zacks.com/stock/news/359873/infinity-inks-deal-with-roche-for-phase-ii-study-of-ipi-549?cid=CS-ZC-FT-359873 Mar 15, 2019 - Shares of Infinity (INFI) rise after the company inks deal with Roche to initiate a phase II MARIO-3 study on IPI-549. Per the deal, Roche will supply Tecentriq (atezolizumab) to Infinity.
Merck's Keytruda Gets EU Approval for Difficult Lung Cancer http://www.zacks.com/stock/news/359869/mercks-keytruda-gets-eu-approval-for-difficult-lung-cancer?cid=CS-ZC-FT-359869 Mar 15, 2019 - Merck (MRK) receives approval for Keytruda's combo therapy for first-line treatment of metastatic squamous non-small cell lung cancer population in Europe.
Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others http://www.zacks.com/stock/news/359854/pharma-stock-roundup-regulatory-updates-from-mrk-pfe-jj-agn-others?cid=CS-ZC-FT-359854 Mar 15, 2019 - Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others.
J&J Seeks Approval for Darzalex in Expanded Patient Group http://www.zacks.com/stock/news/359663/jj-seeks-approval-for-darzalex-in-expanded-patient-group?cid=CS-ZC-FT-359663 Mar 15, 2019 - J&J (JNJ) files sBLA seeking approval for Darzalex combination regimen in newly- diagnosed, transplant ineligible multiple myeloma patient population.
Bristol-Myers Squibb Company (BMY) Management Presents at Barclays 2019 Global Healthcare Conference Call (Transcript) https://seekingalpha.com/article/4248593-bristol-myers-squibb-company-bmy-management-presents-barclays-2019-global-healthcare?source=feed_sector_healthcare Mar 13, 2019 - Bristol-Myers Squibb Company (NYSE:BMY) Barclays 2019 Global Healthcare Conference Call March 13, 2019 12:30 ET Company Participants Charles Bancroft - CFO Conference Call Participants Geoff Meacham -
Bristol-Myers Squibb Co. (BMY) Presents at Cowen Health Care Broker Conference Call (Transcript) https://seekingalpha.com/article/4248291-bristol-myers-squibb-co-bmy-presents-cowen-health-care-broker-conference-call-transcript?source=feed_all_articles Mar 12, 2019 - Bristol-Myers Squibb Co (NYSE:BMY) Cowen Health Care Conference Call March 12, 2019, 11:20 AM ET Company Participants Christopher Boerner - EVP & Chief Commercial Officer Giovanni Caforio - Chairm
Bristol-Myers Squibb Co.'s (BMY) CEO Giovanni Caforio Presents at Cowen Health Care Conference Call (Transcript) https://seekingalpha.com/article/4248291-bristol-myers-squibb-co-s-bmy-ceo-giovanni-caforio-presents-cowen-health-care-conference-call?source=feed_sector_healthcare Mar 12, 2019 - Bristol-Myers Squibb Co. (NYSE:BMY) Cowen Health Care Conference Call March 12, 2019, 11:20 AM ET Company Participants Christopher Boerner - EVP & Chief Commercial Officer Giovanni Caforio - Chair
Celgene (CELG) Submits Application for MS Drug in Europe http://www.zacks.com/stock/news/358951/celgene-celg-submits-application-for-ms-drug-in-europe?cid=CS-ZC-FT-358951 Mar 12, 2019 - Celgene (CELG) submits application for MS drug, ozanimod to the European Medicines Agency.
Bayer Submits Application in EU for Prostate Cancer Drug http://www.zacks.com/stock/news/358754/bayer-submits-application-in-eu-for-prostate-cancer-drug?cid=CS-ZC-FT-358754 Mar 11, 2019 - Bayer (BAYRY) submits an MAA for darolutamide in EU for the treatment of patients with non-metastatic castration-resistant prostate cancer.
Is Bristol-Myers (BMY) a Solid Pick for Value Investors? http://www.zacks.com/stock/news/358745/is-bristol-myers-bmy-a-solid-pick-for-value-investors?cid=CS-ZC-FT-358745 Mar 11, 2019 - Let's see if Bristol-Myers (BMY) stock is a good choice for value-oriented investors right now from multiple angles.

Pages: 1234567891011...78

<<<Page 6>